Bausch Health Completes Acquisition Of Durect Corporation, Expanding Late-Stage Liver Disease Portfolio
Sept 11 (Reuters) - Bausch Health Companies Inc BHC.TO:
BAUSCH HEALTH COMPLETES ACQUISITION OF DURECT CORPORATION, EXPANDING LATE-STAGE LIVER DISEASE PORTFOLIO
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
ORCL Stock: Why Oracle May Be the Beaten-Down Tech Giant Ready for a Comeback

Nvidia Makes First Bet on Legal AI, Invests $50 Million in Legora

POET Technologies Stock Could Still Surge in 2026, but the Bar for a Breakout Is Higher Now

Palantir Q1 2026 Earnings Preview — Is PLTR a Buy at $144?

Amazon vs. Microsoft: Which Stock Is a Better Buy for 2026 and Beyond?

Tradingkey






